Tanzania - English - Tanzania Medicinces & Medical Devices Authority

beta healthcare international limited, kenya - terpeneless dill seed oil , ginger tincture , sodium bicarbonate - liquid - nn

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dch auriga (malaysia) sdn. bhd. - dill seed oil/dill oil; sodium bicarbonate -

Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

jaffar pharmacy - sodium bicarbonate, terpeneless dill seed - oral solution

Ireland - English - HPRA (Health Products Regulatory Authority)

seton products ltd - sodium bicarbonate dill seed oil terpeneless - 0.69mg/5ml %v/v

Australia - English - Department of Health (Therapeutic Goods Administration)

herbal world pty ltd - turnera diffusa, quantity: 37.5 microgram/ml (equivalent: turnera diffusa, qty 150 microgram/ml; equivalent: beta-arbutin, qty 1.05 microgram/ml); oenothera biennis, quantity: 25 microgram/ml (equivalent: oenothera biennis, qty 100 microgram/ml); dioscorea villosa, quantity: 625 microgram/ml (equivalent: dioscorea villosa, qty 2.5 mg/ml); malpighia glabra, quantity: 82.5 microgram/ml (equivalent: malpighia glabra, qty 825 microgram/ml; equivalent: ascorbic acid, qty 10 microgram/ml); matricaria chamomilla, quantity: 125 microgram/ml (equivalent: matricaria chamomilla, qty 500 microgram/ml) - oral liquid - excipient ingredients: potable water; sodium benzoate; carbon dioxide; sucrose; maltodextrin; citric acid; vanillin; linalool; delta-decalactone; neryl acetate; ethyl propionate; ethyl butyrate; citronellal; anethole; methyl benzoate; buchu leaf oil; dimethyl anthranilate; propylene glycol; phenethyl alcohol; mandarin oil; benzyl acetate; ethyl acetate; ethanol; orange oil; phenylacetaldehyde; cis-3-hexen-1-ol; geraniol; trans-2-hexenol; terpinen-4-ol; limonene; citral; maltol; menthone; ethyl caprate; petitgrain oil; isoamyl acetate; davana oil; rose oil; linalyl acetate; geranyl acetate; bergamot oil; benzaldehyde; l-menthyl acetate; orange flower oil; ethyl enantate; benzyl alcohol; alpha-phellandrene; isovaleric acid; geranyl butyrate; lemon oil terpeneless; cinnamon leaf oil; piperonal; gamma-decalactone; jasmine absolute; ginger oil; terpineol; hexyl acetate; acetic acid; 4-(para-hydroxyphenyl)-2-butanone; decanal; alpha-irone; alpha-terpineol; benzyl benzoate; caprylic aldehyde; butylated hydroxytoluene; nerol; sweet orange oil terpenes and terpenoids; geranyl propionate; gamma-heptalactone; linalyl isobutyrate; ethyl salicylate; 2,6-nonadien-1-ol; dwarf pine-needle oil; ambrette seed oil; methyl anthranilate; dimethyl sulfide; lauryl aldehyde; terpinyl acetate - helps reduce/decrease free radical damage to body cells ; maintain/support cardiovascular system health ; decrease/reduce/relieve diarrhoea ; help maintain/support emotional wellbeing ; decrease/reduce/relieve symptoms of common cold ; decrease/reduce/relieve cough ; decrease/reduce/relieve throat irritation

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - lemon oil terpeneless; glycerol; citric acid monohydrate; syrup; honey purified - oral solution - 100nanolitre/1ml ; 50microlitre/1ml ; 5mg/1ml ; 750microlitre/1ml ; 100mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - metronidazole benzoate, quantity: 64 mg/ml - oral liquid, suspension - excipient ingredients: ethanol; monobasic sodium phosphate; aluminium magnesium silicate; methyl hydroxybenzoate; sucrose; propyl hydroxybenzoate; orange oil terpeneless; flavour - anaerobic infections treatment of infections in which anaerobic bacteria have been identified or are suspected as pathogens, particularly bacteroides fragilis and other species of bacteroides, and other species such as fusobacteria, eubacteria, clostridia and anaerobic streptococci. flagyl has been used successfully in septicaemia; bacteraemia; brain abscess; necrotising pneumonia; osteomyelitis; puerperal sepsis; pelvic abscess; pelvic cellulitis; postoperative wound infections. notes. 1. because of the slow absorption and delayed peak plasma level, flagyl suspension is not recommended for use in the acute situation. 2. metronidazole is inactive against aerobic and facultative anaerobic bacteria. other indications oral treatment of urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male, and for the treatment of bacterial vaginosis. the male consort of females suffering from urogenital trichomoniasis should be treated concurrently; all forms of amoebiasis( intestinal and extraintestin

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - phenytoin 6 mg/ml - oral suspension - 30 mg/5ml - active: phenytoin 6 mg/ml excipient: aluminium magnesium silicate carmellose sodium carmoisine citric acid monohydrate ethanol imitation banana flavour 510120e glycerol polysorbate 40 purified water sodium benzoate sucrose sunset yellow fcf terpeneless orange oil vanillin

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - metronidazole benzoate 64 mg/ml equivalent to 40 mg/ml metronidazole.;  ;   - oral suspension - 200 mg/5ml - active: metronidazole benzoate 64 mg/ml equivalent to 40 mg/ml metronidazole.     excipient: aluminium magnesium silicate citrus limon ethanol methyl hydroxybenzoate monobasic sodium phosphate dihydrate propyl hydroxybenzoate purified water sucrose liquid terpeneless orange oil

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - lemon oil terpeneless; ethanol 95% - not applicable - 100ml/1litre ; 900ml/1litre